AI
INSP icon

Axiom Investors’s Inspire Medical Systems INSP Stock Holding History

Axiom Investors’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-27,201
Closed -$5.53M – 144
2023
Q4 		$5.53M Buy
27,201
+8,429
+45% +$1.37M 0.05% 104
2023
Q3 		$3.73M Sell
18,772
-12,068
-39% -$3.04M 0.05% 78
2023
Q2 		$10M Sell
30,840
-4,287
-12% -$1.22M 0.15% 56
2023
Q1 		$8.22M Sell
35,127
-3,565
-9% -$901K 0.14% 64
2022
Q4 		$9.75M Buy
38,692
+19,153
+98% +$4.08M 0.19% 69
2022
Q3 		$3.47M Buy
19,539
+778
+4% +$156K 0.07% 96
2022
Q2 		$3.43M Buy
18,761
+430
+2% +$85.8K 0.1% 87
2022
Q1 		$4.71M Buy
18,331
+8,898
+94% +$2.03M 0.11% 82
2021
Q4 		$2.17M Sell
9,433
-2,860
-23% -$698K 0.04% 106
2021
Q3 		$2.86M Sell
12,293
-1,589
-11% -$332K 0.05% 107
2021
Q2 		$2.68M Sell
13,882
-3,919
-22% -$777K 0.04% 110
2021
Q1 		$3.69M Buy
+17,801
New +$3.78M 0.07% 105

Other funds holding INSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Axiom Investors's INSP Position: Q1 2024 in Review

Axiom Investors sold out of Inspire Medical Systems (INSP) in Q1 2024, closing a stake of 27,201 shares — an estimated $5.53M sold.

Axiom Investors first reported a position in INSP in Q1 2021 and held it in 12 quarters. The position peaked at $10M in Q2 2023. 328 funds tracked by Wall St. Rank hold INSP as of Q1 2024.

  • Axiom Investors reported no remaining Inspire Medical Systems position as of Q1 2024 after selling out during the quarter.
  • Axiom Investors sold 27,201 Inspire Medical Systems shares in Q1 2024, an estimated $5.53M.
  • Axiom Investors first reported a position in Inspire Medical Systems in Q1 2021 and held it in 12 quarters.
  • Axiom Investors's Inspire Medical Systems position peaked at $10M in Q2 2023.
  • 328 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2024.

Based on Axiom Investors's 13F filing for Q1 2024, filed 13 May 2024.